Table 5.
ROC analysis of clinical risk assessment tools for Τ-score≤-2.5 and Τ-score>-2.5.
| AUC | SE | 95% CI | p-value | Cut-off point | Sensitivity | Specificity | PPV | NPV | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SCORE* | 0.672 | 0.039 | 0.60 | 0.75 | <0.0005 | 7.5 | 84% | 44% | 27% | 90% |
| ORAI Score* | 0.643 | 0.044 | 0.56 | 0.73 | 0.001 | 9.0 | 70% | 60% | 31% | 88% |
| ABONE Score* | 0.636 | 0.045 | 0.55 | 0.72 | 0.002 | 1.5 | 51% | 76% | 35% | 86% |
| OST Score† | 0.690 | 0.038 | 0.62 | 0.76 | <0.005 | 2.95 | 89% | 45% | 30% | 94% |
| Osiris Score† | 0.696 | 0.037 | 0.62 | 0.77 | <0.005 | 2.50 | 79% | 51% | 30% | 90% |
| Osiris Adjusted Score† | 0.680 | 0.038 | 0.61 | 0.75 | <0.005 | 2.50 | 77% | 50% | 28% | 89% |
AUC: Area Under the Curve. SE: Standard Error. CI: Confidence Interval.
*
Larger values of the test result variable indicate stronger evidence for Τ-score≤-2.5.
†
Smaller values of the test result variable indicate stronger evidence for Τ-score≤-2 .5.